Home Tools
Log in
Cart

Search Result

Search Results for " bet-in-4 "

8

Compounds

Cat No. Product Name Synonyms Targets
T10521 ODM-207 BET-IN-4,ODM207 Epigenetic Reader Domain
ODM-207 (BET-IN-4) is a potent BRD4 inhibitor.
T2120 I-BET151 GSK1210151A Epigenetic Reader Domain
I-BET151 (GSK1210151A) (GSK1210151A) is a specific BET inhibitor for BRD2/3/4 (IC50: 0.5/0.25/0.79 μM, in cell-free assays).
T4697 ABBV-744 ABBV744 Epigenetic Reader Domain , HIV Protease
ABBV-744 is a BDII-selective BET bromodomain inhibitor that inhibits BRD2/3/4. It is used in the research on inflammatory diseases, cancer, and AIDS.
T27392 FT001 Epigenetic Reader Domain
FT001 is a potent, selective and orally available inhibitor of BET Bromodomain with antitumor activity. FT001 inhibited the expression of MYC with the IC50 value of 0.46 μM). FT001 has potent antiproliferative effects ag...
T10522 BET-IN-6 Epigenetic Reader Domain
BET-IN-6, a ligand with potent and high affinity for inhibiting BRD2/BRD4, plays a crucial role in the synthesis of PROTAC BRD2/BRD4 degrader-1 [1], targeting the protein BRD2/4.
T36574 GW841819X GW841819X
GW841819X is an analogue of (+)-JQ1 and a novel inhibitor of BET bromodomains. GW841819X was a single enantiomer but of undefined chirality at the 4-position of the benzodiazepine ring3. GW841819X and JQ1 were recently d...
T36800 EN219
EN219 is a synthetic recruiter of the E3 ubiquitin ligase RNF114.1It binds to cysteine 8 (C8) in the intrinsically disordered region of RNF114 (RNF114-C8; IC50= 470 nM) and inhibits RNF114-induced autoubiquitination and ...
T36103 TW9 TW9
TW9 is a dual inhibitor of bromodomain 2 (BD2) in bromodomain-containing protein 4 (BRD4) and histone deacetylase 1 (HDAC1; IC50s = 0.074 and 0.29 μM, respectively).1It is selective for BD2 over BD1 in BRD4 (IC50= 0.72 μ...
TargetMol